Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kane Biotech (TSE:KNE)
:KNE
Holding TSE:KNE?
Track your performance easily
KNE Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.08 - C$0.17
Previous CloseN/A
Volume199.87K
Average Volume (3M)86.28K
Market Cap
C$13.75M
Enterprise ValueC$20.47M
Total Cash (Recent Filing)$739.57K
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.55
Next Earnings
Apr 01, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding137,511,570
10 Day Avg. Volume102,028
30 Day Avg. Volume86,280
Standard Deviation0.13
R-Squared0.04
Alpha-0.00054
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)257.40
Price to Cash Flow (P/CF)-6.10
P/FCF Ratio0.00
Enterprise Value/Market Cap1.49
Enterprise Value/Revenue399.60
Enterprise Value/Gross Profit186.98
Enterprise Value/Ebitda-6.13
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Kane Biotech News
PremiumCompany Announcements
Kane Biotech’s Promising Q3 and Strategic Advances
PremiumCompany Announcements
Kane Biotech Partners with BioStem for U.S. DistributionPremiumCompany Announcements
Kane Biotech to Announce Q3 Financial Results
PremiumCompany Announcements
Kane Biotech Expands with FB Dermatology Acquisition
PremiumCompany Announcements
Kane Biotech Expands with FB Dermatology Acquisition
PremiumCompany Announcements
Kane Biotech Expands with New Distribution Deal
PremiumCompany Announcements
Kane Biotech Initiates Global Wound Care Collaboration
PremiumCompany Announcements
Kane Biotech to Showcase Wound Care InnovationsOptions Prices
Currently, No data available
---
Ownership Overview
KNE FAQ
What was Kane Biotech’s price range in the past 12 months?
Kane Biotech lowest stock price was C$0.07 and its highest was C$0.17 in the past 12 months.
What is Kane Biotech’s market cap?
Kane Biotech’s market cap is C$13.75M.
When is Kane Biotech’s upcoming earnings report date?
Kane Biotech’s upcoming earnings report date is Apr 01, 2025 which is in 73 days.
How were Kane Biotech’s earnings last quarter?
Kane Biotech released its earnings results on Nov 28, 2024. The company reported -C$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.005.
Is Kane Biotech overvalued?
According to Wall Street analysts Kane Biotech’s price is currently Overvalued.
Does Kane Biotech pay dividends?
Kane Biotech does not currently pay dividends.
What is Kane Biotech’s EPS estimate?
Kane Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kane Biotech have?
Kane Biotech has 137,511,570 shares outstanding.
What happened to Kane Biotech’s price movement after its last earnings report?
Kane Biotech reported an EPS of -C$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Kane Biotech?
Currently, no hedge funds are holding shares in TSE:KNE
---
Company Description
Kane Biotech
Kane Biotech Inc is a Canada based biotechnology company engaged in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms. The company's human health product is DispersinB and animal health products include bluestem oral care, STRIX NB, and Alosera. In addition, the company also provides technologies for industrial applications such as medical device coating and hard surface disinfectant.
---
Technical Analysis
---